The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Harpoon Therapeutics, Inc(NASDAQ:HARP) 
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company's lead tri-specific t-cel...
Website: http://www.harpoontx.com
Founded: 2015
Full Time Employees: 77
Sector: Healthcare
Industry: Biotechnology
Harpoon Therapeutics Days Payable Outstanding ttm (DPO)
Harpoon Therapeutics Op Cashflow Per Share ttm
Harpoon Therapeutics Free Cashflow Per Share ttm
Harpoon Therapeutics Cash Per Share ttm
Harpoon Therapeutics P/S ratio ttm
Harpoon Therapeutics (GAAP) P/E ratio ttm
Harpoon Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.